Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology?Koopman WJ; Verkaart S; Visch HJ; van Emst-de Vries S; Nijtmans LG; Smeitink JA; Willems PHAm J Physiol Cell Physiol 2007[Jul]; 293 (1): C22-9Malfunction of NADH:ubiquinone oxidoreductase or complex I (CI), the first and largest complex of the mitochondrial oxidative phosphorylation system, has been implicated in a wide variety of human disorders. To demonstrate a quantitative relationship between CI amount and activity and mitochondrial shape and cellular reactive oxygen species (ROS) levels, we recently combined native electrophoresis and confocal and video microscopy of dermal fibroblasts of healthy control subjects and children with isolated CI deficiency. Individual mitochondria appeared fragmented and/or less branched in patient fibroblasts with a severely reduced CI amount and activity (class I), whereas patient cells in which these latter parameters were only moderately reduced displayed a normal mitochondrial morphology (class II). Moreover, cellular ROS levels were significantly more increased in class I compared with class II cells. We propose a mechanism in which a mutation-induced decrease in the cellular amount and activity of CI leads to enhanced ROS levels, which, in turn, induce mitochondrial fragmentation when not appropriately counterbalanced by the cell's antioxidant defense systems.|*Oxidative Phosphorylation/drug effects[MESH]|Cell Line[MESH]|Child[MESH]|Cluster Analysis[MESH]|Electron Transport Complex I/antagonists & inhibitors/deficiency/genetics/*metabolism[MESH]|Electrophoresis[MESH]|Enzyme Inhibitors/pharmacology[MESH]|Fibroblasts/drug effects/enzymology/*metabolism/pathology[MESH]|Genetic Predisposition to Disease[MESH]|Humans[MESH]|Membrane Potential, Mitochondrial[MESH]|Microscopy, Confocal[MESH]|Microscopy, Video[MESH]|Mitochondria/drug effects/enzymology/*metabolism/pathology[MESH]|Mitochondrial Diseases/enzymology/genetics/*metabolism/pathology[MESH]|Mitochondrial Proteins/metabolism[MESH]|Mitochondrial Size[MESH]|Mutation[MESH]|Reactive Oxygen Species/*metabolism[MESH]|Reproducibility of Results[MESH]|Rotenone/pharmacology[MESH]|Severity of Illness Index[MESH]|Uncoupling Agents/pharmacology[MESH] |
